← All Mink Therapeutics, INC filings

Mink Therapeutics, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
INKT
Mink Therapeutics, INC
DEF: MiNK Therapeutics 2026 Annual Meeting Proxy Statement
MiNK Therapeutics announces its 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026.
NASDAQ
INKT
Mink Therapeutics, INC
DEF: MiNK Therapeutics Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
MiNK Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 18, 2025, featuring proposals including director elections, an option exchange, and ratification of the company's accounting firm.
NASDAQ
INKT
Mink Therapeutics, INC
DEF 14A: MiNK Therapeutics Proposes Reverse Stock Split to Maintain Nasdaq Listing
MiNK Therapeutics is seeking stockholder approval for a 1-for-10 reverse stock split to maintain compliance with Nasdaq's minimum bid price requirement.
NASDAQ
INKT
Mink Therapeutics, INC
DEF 14A: MiNK Therapeutics Sets Date for 2024 Annual Stockholder Meeting, Outlines Key Proposals
MiNK Therapeutics announces its 2024 Annual Meeting of Stockholders to be held virtually on June 12, 2024, featuring proposals for director elections and auditor ratification.